Seventeenth Annual Pediatric Endocrinology and Diabetes Symposium

Monday, November 12, 2018, 8:15 AM - 12:30 PM, Kenneth L. Davis Auditorium, Hess Center for Science and Medicine, Icahn School of Medicine at Mount Sinai


In light of recent advances in the care of transgender youth and youth with diabetes and growth disorders, the Mount Sinai Division of Pediatric Endocrinology and Diabetes seeks to empower a broad array of clinicians to provide the highest level of care to people with diabetes and growth disorders and transgender individuals. Participants will learn about pathophysiology, treatment goals and methods for diabetes and growth disorders, current issues related to the care of transgender youth, and will emerge more confident dealing with diabetes and endocrine challenges.

1. - Identify the underlying etiologies of growth disorders and understand a systematic approach to hormonal and genetic testing in the subgroup of patients with short stature
2. - Recognize clinical evidence based advances in the treatment of type II Diabetes Mellitus
3. - Understand the affirmative approach to the health care of transgender children and understand how recommendations have changed in the recent guidelines.

Practicing Physician - $60.00

MSHS Allied Health Professional - $30.00

Resident/Fellow/Medical Student - Complimentary*

**PLEASE EMAIL A COPY OF YOUR HOSPITAL ID TO [email protected] TO RECEIVE A COMPLIMENTARY REGISTRATION CODE**

Cancellation Policy

A $50.00 administrative fee will be deducted from all refunds/cancellations issued. All refund and cancellation requests must be emailed to the CME Office at [email protected] by October 18, 2018. No refunds will be made after this date for cancellations and "no-shows".

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™ (3.25 hours), Non-Physician Attendance (3.25 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Monday, November 12, 2018